| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on IDEX (NYSE:IEX) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 0 | 0 |
Analysts have recently evaluated IDEX and provided 12-month price targets. The average target is $253.17, accompanied by a high estimate of $277.00 and a low estimate of $215.00. This current average reflects an increase of 8.94% from the previous average price target of $232.40.
The perception of IDEX by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Bryan Blair | Oppenheimer | Raises | Outperform | $252.00 | $245.00 |
| Vladimir Bystricky | Citigroup | Raises | Buy | $277.00 | $254.00 |
| Deane Dray | RBC Capital | Maintains | Outperform | $255.00 | - |
| Deane Dray | RBC Capital | Raises | Outperform | $255.00 | $234.00 |
| Nathan Jones | Stifel | Raises | Buy | $265.00 | $215.00 |
| Nathan Jones | Stifel | Raises | Hold | $215.00 | $214.00 |
For valuable insights into IDEX's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on IDEX analyst ratings.
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: IDEX's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately -2.69%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: IDEX's net margin is impressive, surpassing industry averages. With a net margin of 13.77%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): IDEX's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.13%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): IDEX's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.88%, the company may face hurdles in achieving optimal financial performance.
Debt Management: IDEX's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.41.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IEX
